Skip to content

Drug interactions

Rivaroxaban + Vorapaxar

Severity: Major

Rivaroxaban and Vorapaxar: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vorapaxar is a platelet protease-activated receptor-1 antagonist, and adding an anticoagulant increases bleeding risk including intracranial hemorrhage. Together they impair both platelet and coagulation pathways.

What this interaction means in plain words

Rivaroxaban and Vorapaxar can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic effects from platelet inhibition and factor Xa inhibition.

What to do

Avoid unless the benefit clearly outweighs bleeding risk; if used, monitor closely for bleeding. Vorapaxar is contraindicated with prior stroke, TIA or intracranial hemorrhage.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rivaroxaban and Vorapaxar, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rivaroxaban with Vorapaxar?

MediHelp rates the interaction as major. Rivaroxaban and Vorapaxar can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Vorapaxar is a platelet protease-activated receptor-1 antagonist, and adding an anticoagulant increases bleeding risk including intracranial hemorrhage. Together they impair both platelet and coagulation pathways.

How serious is the interaction between Rivaroxaban and Vorapaxar?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid unless the benefit clearly outweighs bleeding risk; if used, monitor closely for bleeding. Vorapaxar is contraindicated with prior stroke, TIA or intracranial hemorrhage.

What other medicines interact with Rivaroxaban?

MediHelp also lists interactions of Rivaroxaban with, for example, Defibrotide, Ketoconazole, Ketorolac. The full list is on the Rivaroxaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in